Supply Chain Mayhem: Industry Impacts and What Can be Done
Major international emergencies such as the COVID-19 pandemic and the ongoing conflict in Ukraine have led to supply chain disruptions for FDA-regulated companies. During this webinar, speakers will discuss: 1) specific impacts of supply chain disruptions on FDA-regulated industry; 2) findings from the FDA’s 2021 100-day review of supply chains and reports on outcomes one year later; 3) ways that companies can mitigate risks posed by unexpected shortages or problems getting access to components of regulated products from third-party manufacturers; 4) federal efforts to stimulate domestic manufacturing of critical medical products and other FDA-regulated components; and 5) how organizations have rethought and rebuilt their supply chains to be more agile, efficient, and sustainable.
Christina Anderson Mooney, Senior Legal Director, Medtronic Amy Norris, Executive Counsel, Clif Bar & Company and Member, FDLI Board of Directors Moderated byWinston Kirton, Partner, BakerHostetler
We use Zoom to conduct webinars which works on most devices. You may participate in the webinar on a mobile device via the Zoom App or by dialing in. If you require the dial in information, please contact Coleen Carney at [email protected].